February 28, 2008 / 10:00 PM / 12 years ago

P&G wins patent lawsuit for osteoporosis therapy against Teva

Feb 28 (Reuters) - Procter & Gamble Co (PG.N) said it won a patent infringement lawsuit for osteoporosis therapy Actonel against Teva Pharmaceuticals USA Inc.

Procter & Gamble said the ruling of U.S. District Court of Delaware protects P&G’s rights in the U.S. to exclusively market the osteoporosis therapy Actonel. The ruling upheld the P&G patent, rejecting Teva’s validity challenge, it added.

The Actonel patent life extends through the end of 2013, excluding any potential extensions, P&G said in a statement. (Reporting by Dilipp S. Nag in Bangalore; Editing by Anil D’Silva)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below